Clinical Trials Management, LLC | Northshore, Covington, LA

Research site

Location

7043 Highway 190 E Service Road, Suite C, Covington, Louisiana, United States of America

Site insights

Top conditions

Top treatments

Elagolix

Vonoprazan

SCY-078

Lansoprazole

Fluconazole

Estradiol

Norethindrone Acetate

Triglyceride

K-877

Relugolix

Parent organization

This site is a part of Clinical Trials Management, LLC

Data sourced from clinicaltrials.gov

Active trials

9 of 33 total trials

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

This is a Phase 3, open-label study to evaluate the long-term safety of difamilast ointment 1% in subjects ≥2 years of age with mild to moderate AD....

Active, not recruiting

Atopic Dermatitis

Drug: Difamilast

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for...

Enrolling

Uterine Fibroids

Endometriosis

Drug: Relugolix Combination Tablet

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

The objective of the Healing Phase of the study is to evaluate the safety and efficacy of up to 8 weeks of once daily oral administration of BLI5100...

Enrolling

Erosive Esophagitis

Drug: PPI Control

Drug: BLI5100

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

This study is an open-label, uncontrolled study design to evaluate the long-term safety and tolerability of treatment with CC-93538. The study will e...

Enrolling

Eosinophilic Esophagitis

Drug: CC-93538

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Placebo

Drug: Inclisiran sodium 300 mg

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Enrolling

Endometriosis

Drug: Elagolix

Drug: Placebo

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy (SERENE)

The purpose of this study is to assess the contraceptive efficacy of relugolix combination therapy.

Active, not recruiting

Contraception

Drug: Relugolix Combination Therapy

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting

Contraception

Drug: MR-100A-01

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients (EURELIA2)

The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the effi...

Enrolling

Hyperuricemia

Tophi

Drug: Tigulixostat

Drug: Placebo